Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for DSNKY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 25.32B
March 31, 2026 25.18B
December 31, 2025 24.38B
September 30, 2025 24.17B
June 30, 2025 23.95B
March 31, 2025 23.11B
December 31, 2024 21.91B
September 30, 2024 23.05B
June 30, 2024 21.37B
March 31, 2024 22.87B
December 31, 2023 23.19B
September 30, 2023 17.75B
June 30, 2023 18.10B
March 31, 2023 18.85B
December 31, 2022 18.17B
September 30, 2022 16.77B
June 30, 2022 16.89B
March 31, 2022 18.30B
December 31, 2021 18.79B
September 30, 2021 18.92B
June 30, 2021 18.58B
March 31, 2021 18.87B
December 31, 2020 19.87B
September 30, 2020 19.71B
June 30, 2020 19.12B
Date Value
March 31, 2020 19.50B
December 31, 2019 19.23B
September 30, 2019 18.91B
June 30, 2019 19.13B
March 31, 2019 18.86B
December 31, 2018 17.26B
September 30, 2018 16.80B
June 30, 2018 17.08B
March 31, 2018 17.84B
December 31, 2017 17.35B
September 30, 2017 17.29B
June 30, 2017 17.27B
March 31, 2017 17.19B
December 31, 2016 17.04B
September 30, 2016 18.97B
June 30, 2016 17.96B
March 31, 2016 16.91B
December 31, 2015 16.20B
September 30, 2015 15.87B
June 30, 2015 15.75B
March 31, 2015
December 31, 2014 16.38B
September 30, 2014 16.76B
June 30, 2014 17.34B
March 31, 2014

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Astellas Pharma, Inc. 22.72B
AstraZeneca PLC 114.02B
Takeda Pharmaceutical Co., Ltd. 96.37B
Ono Pharmaceutical Co., Ltd. 6.672B
Shionogi & Co., Ltd. 16.34B

Total Assets (Quarterly) Related Metrics